Tauriga Sciences, Inc.
TAUG · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21.7% | 310.2% | 4,709.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43% | 15.9% | 35% | 39.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -887.3% | -908.8% | -1,429% | -165,982.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,271% | -1,294.1% | -1,920.8% | -3,041% |
| EPS Diluted | -0.024 | -0.049 | -0.02 | -0.001 |
| % Growth | 49.8% | -143% | -3,233.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |